Nguyen AnhCo 4
4 · Atara Biotherapeutics, Inc. · Filed Nov 19, 2025
Insider Transaction Report
Form 4
Nguyen AnhCo
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-11-17$13.19/sh−2,859$37,699→ 65,030 total - Sale
Common Stock
2025-11-17$13.19/sh−56$739→ 64,974 total
Footnotes (2)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 17, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.